Research advances of exosomal micrornas in regulating the pathogenesis of acute lung injury/acute respiratory distress syndrome.
10.3760/cma.j.cn121430-20240802-00659
- Author:
Lingshuang CHEN
1
;
Jun LYU
2
,
3
;
Xianming ZHANG
1
Author Information
1. Department of Respiratory Medicine, the Affiliated Hospitalof Guizhou Medical University, Guiyang 550004, Guizhou, China.
2. Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan 250000, Shandong, China. Corresponding author: Zhang Xianming, Email: 13078524367@
3. com.
- Publication Type:English Abstract
- MeSH:
Exosomes;
Humans;
MicroRNAs;
Acute Lung Injury;
Respiratory Distress Syndrome;
Animals
- From:
Chinese Critical Care Medicine
2025;37(5):494-498
- CountryChina
- Language:Chinese
-
Abstract:
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a severe critical condition marked by rapid progression and high fatality. It results from direct/indirect lung-related or systemic triggers, leading to widespread injury of lung epithelial and endothelial cells. Its pathogenesis involves uncontrolled inflammation and breakdown of the lung's blood-air barrier due to leaky blood vessels and epithelial damage. Current management of ALI/ARDS remains primarily supportive, offering symptomatic relief but limited improvement in prognosis, necessitating deeper exploration of upstream pathogenic mechanisms to identify safer and more effective therapies. Exosomal microRNAs (miRNA), small extracellular vesicles (40-150 nm) containing non-coding single-stranded RNAs, regulate post-transcriptional cellular processes and participate in ALI/ARDS pathophysiology. Studies reveal that exosomes transport proteins, nucleic acids, and miRNAs to recipient cells, mediating intercellular communication. In ALI/ARDS models, exosomal miRNAs delivered to alveolar epithelial cells, endothelial cells, macrophages, and neutrophils critically modulate autophagy, pyroptosis, apoptosis, proliferation, inflammatory signaling, macrophage polarization, and neutrophil activation, either exacerbating or alleviating disease progression. Recent advances in engineering techniques have enhanced the therapeutic potential of exosomal miRNAs by overcoming limitations of natural exosomes. This review focuses on exosomal miRNA-mediated regulation of ALI/ARDS pathogenesis across key cell types, providing insights for novel therapeutic strategies.
